Zentalis Pharmaceuticals, Inc. Common Stock
$3.16
$0.08 (+2.60%)
$2.99Day Range$3.17
Key Statistics
Market Cap
$291.59M
Shares Outstanding
94.7M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Apr 3, 2020
Round Lot
100
Locale
US
Trading Data
Day Open
$3.07
Day High
$3.17
Day Low
$2.99
Volume
441.7K
VWAP
$3.07
Prev Close
$3.08
Transactions
--
Acc. Volume
--
About Zentalis Pharmaceuticals, Inc. Common Stock
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
PHARMACEUTICAL PREPARATIONSSIC 2834106 employees10275 SCIENCE CENTER DRIVE, SAN DIEGO, CA, 92121(858) 263-4333IPO Apr 3, 2020US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001725160
- Composite FIGI
- BBG00R2K8TF5
- Share Class FIGI
- BBG00R2K8TG4
- Ticker Root
- ZNTL
- SIC Code
- 2834
About Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL) Stock
Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL) closed the 2026-09-18 session at $3.16, up 2.60% versus the previous close (+0.08). The stock opened at $3.07 and traded between $2.99 and $3.17 during that session. Session trading volume was 442K shares. The volume-weighted average price (VWAP) is $3.07.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
Zentalis Pharmaceuticals, Inc. Common Stock has a market capitalization of $291.6 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. ZNTL is listed on the XNAS exchange. The company employs approximately 106 people. Zentalis Pharmaceuticals, Inc. Common Stock is headquartered in SAN DIEGO, CA. The recorded listing date is 2020-04-03.
On this page you can find market ZNTL stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.